Document is current

Article History

Received: 27 February 2025

Accepted: 23 April 2025

First Online: 29 May 2025

Declarations

:

: Vimal H. Prajapati has served as an advisor, consultant, and/or speaker for AbbVie, Actelion, Amgen, Apogee Therapeutics, Aralez Bio, Arcutis Biotherapeutics, Aspen, Bausch Health/Valeant BioScript Solutions, Boehringer Ingelheim, Bristol Myers Squibb, the Canadian Psoriasis Network, Celgene Corporation, Celltrion, Cipher, CorEvitas, Eli Lilly, Galderma, GSK, Homeocan, Incyte, JAMP Pharma, Janssen, J&J Innovative Medicine, Johnson & Johnson, Kevnue, LEO Pharma, Medexus, Novartis, Organon, Pediapharm, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sun Pharma, Tribute, and UCB; been an investigator for AbbVie, Alumis, AnaptysBio, Apogee Therapeutics, Apollo Therapeutics, Arcutis Biotherapeutics, Arena, Asana, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Concert Pharmaceuticals (acquired by Sun Pharma in March 2023), CorEvitas, Dermavant Sciences, Dermira, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Nektar Therapeutics, Nimbus Lakshmi, Novartis, Pfizer, RAPT Therapeutics, Regeneron Pharmaceuticals, Reistone Biopharma, Roche/Genentech, Sanofi, Sun Pharma, Takeda, UCB, and Vyne Therapeutics; and received grants from AbbVie, Bausch Health, Janssen, LEO Pharma, Novartis, and Sanofi. Nicole Bellefontaine and Rommel Mangaser are employees of Bayshore HealthCare. Devi Gopalan is a former employee of Bayshore HealthCare. Pak Chan is an employee of Sun Pharma Canada Inc. Maxwell B. Sauder has served as an advisor, consultant, and/or speaker for AbbVie, Alumis, Amgen, Apogee Therapeutics, Aralez Bio, Arcutis Biotherapeutics, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, the Canadian Psoriasis Network, Eli Lilly, Fresenius Kabi Canada, Galderma, Incyte, Janssen, Johnson & Johnson, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Sanofi, Sun Pharma, UCB, and Viatris; and has been an investigator for AbbVie, Alumis, Amgen, Bristol Myers Squibb, Dermavant Sciences, Evelo Biosciences, Galderma, Incyte, Janssen, LEO Pharma, Meiji Seika Pharma, Moberg Pharma, Novartis, Pfizer, Reistone Biopharma, Sanofi, and Ventyx Biosciences.

: The study was exempt from institutional review board approval as it only used anonymized data. This study was conducted in accordance with ethical principles outlined in the Declaration of Helsinki, is consistent with Good Pharmacoepidemiology Practices and the Strengthening the Reporting of Observational Studies in Epidemiology guidelines, and conforms to applicable data and privacy laws. All patients participating in this study provided informed consent for their data to be used for research purposes.